Todd C. Brady, President and CEO at Aldeyra Therapeutics, Inc. (ALDX), bought 40,094 shares at $5.90 ($237K) on 2019-09-13, disclosed to the SEC on 2019-09-17.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.90 | 18,547 | $109K | 46.2% |
| 2 | $5.90 | 18,547 | $109K | 46.2% |
| 3 | $6.03 | 3,000 | $18K | 7.6% |
| Total | $5.91 avg | 40,094 | $237K | 100% |
| Filing → |
| ALDX | BUY | 2022-06-27 | $59K | — | Filing → |
| ALDX | BUY | 2019-12-18 | $102K | — | Filing → |
| ALDX | BUY | 2019-10-02 | $49K | — | Filing → |